Skip to main content

Table 4 Day 1 and day 7 characteristics of participants completing the trial per protocol

From: Identification of a botanical inhibitor of intestinal diacylglyceride acyltransferase 1 activity via in vitro screening and a parallel, randomized, blinded, placebo-controlled clinical trial

Characteristics Test Day Placebo APE GE RLE ANE
N (Male/Female)   17 (9/8) 15 (7/8) 15 (6/9) 17 (6/11) 17 (11/6)
Age (years)   46.7 ± 9.9 47.0 ± 9.3 52.7 ± 12.6 46.8 ± 8.2 48.4 ± 9.0
Body Weight (kg) 1 90.8 ± 14.7 91.0 ± 10.4 88.3 ± 15.1 86.3 ± 13.6 87.9 ± 9.7
  7 90.8 ± 14.7 91.1 ± 10.7 88.0 ± 15.3 86.3 ± 13.6 88.0 ± 9.6
BMI 1 30.2 ± 3.9 32.0 ± 1.8 30.8 ± 2.9 30.8 ± 3.5 30.4 ± 3.5
  7 30.1 ± 3.9 32.0 ± 1.9 30.7 ± 3.0 30.5 ± 3.4 30.4 ± 3.5
Total Cholesterol (mg/dL) 1 206 ± 41 183 ± 30 190 ± 46 196 ± 34 200 ± 46
  7 195 ± 44 170 ± 25 175 ± 35 191 ± 31 184 ± 35
LDL-C (mg/dL) 1 135 ± 42 116 ± 30 115 ± 42 123 ± 34 133 ± 43
  7 129 ± 43 107 ± 25 105 ± 29 117 ± 34 119 ± 35
HDL-C (mg/dL) 1 50.3 ± 18.1 51.0 ± 17.2 58.7 ± 17.2 57.8 ± 17.7 50.1 ± 12.5
  7 48.2 ± 19.4 46.3 ± 13.5 55.4 ± 19.8 54.8 ± 19.2 46.8 ± 11.2
TG (mg/dL) 1 97.5 ± 39.8 96.7 ± 39.8 101.7 ± 38.7 102.3 ± 35.8 111.1 ± 46.8
  7 95.8 ± 36.2 94.7 ± 26.4 90.3 ± 23.8 102.1 ± 57 103.8 ± 40.4
  1. There were no statistically significant differences in any of the measured anthropometric or serum lipids between groups at day 1 or at day 7. Results are Mean ± SD